Acquisition highlights of Genes2me and a snapshot of its key metrics.

A snapshot of cap table and shareholder metrics

Founded in 2016, Genes2Me operates in Health Tech offering innovative in vitro diagnostic solutions and genetic testing services. The company manufactures a range of advanced products including NGS clinical panels, molecular POC testing solutions, and RT-PCR kits designed for various health conditions. Genes2Mes testing services encompass infectious and non-infectious diseases, oncology, and prenatal/postnatal genetic diseases. The company aims to transform molecular Point of Care testing with its flagship products, Rapi-Q, Rapi-Q HT, and Rapid POC RT-PCR device. Through its cutting-edge technology, Genes2Me seeks to enhance healthcare diagnostics in India and beyond.

Neeraj Gupta

Funding highlights of Genes2me and a snapshot of its key metrics.

Investment highlights of Genes2me and a snapshot of its key metrics.

Read the latest news on Genes2me covering funding updates, financials, leadership changes and key announcements on Inc42.

Genes2me Latest News 2026 – Funding, Financials & Updates

Genes2me

A snapshot of highlights, scale, and metrics

A Health Tech Bootstrapped Company Based Out Of Gurugram

Genes2me - Latest News, Analysis, Funding, Financials & More

Whoops! We've hit a dead end here.